21 November 2017
News and Views
Links and Services
December's issue of Gut evaluates the effect of aspirin and NSAIDs on risk and survival from colorectal cancer.
Previous studies have shown that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs)
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors